ArticleEuropean clinical respiratory journal2026
Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.
Hatice Serpil Akten et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.